Translational

The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs by offering funding, education and project-specific mentorship.

The Stanford Innovative Medicines Accelerator (IMA) is accepting proposals for projects that address two major challenges in drug development: identification of drug candidates and optimization towards clinical gene and cell therapy products.

Novartis is awarding $100,000 to $300,000 for 1 year for translational research that can contribute to their early-stage pipeline and ultimately benefit patients. Please fill in the Pre-Proposal Submission Word Template before August 1, 2024.

Stanford HAI seeks proposals that support new, ambitious, and speculative ideas in AI with the objective of getting initial results. We expect to award approximately 25 grants, up to $75,000 each with the possibility of an additional $10,000 for public policy analysis.

The Stanford Innovative Medicines Accelerator (IMA) is accepting proposals for human subjects research that fosters the clinical development of new or existing drugs, vaccines, and companion biomarkers that directly enable drug development.

Grants up to $250,000 along with strategic and advisory support to accelerate the commercial delivery of Stanford-based innovations from across the University.

The Stanford Innovative Medicines Accelerator (IMA) is accepting proposals for projects that address two major challenges in small molecule drug discovery: adaptation of lab-grade assays to high- throughput
screening (HTS) formats and optimization of lead compounds into drug prototypes.

Sanofi is awarding $150,000 funding for 1 year for translational research that can contribute to their early-stage pipeline and ultimately benefit patients. Please fill in the Pre-Proposal Submission Word Template before May 24th, 2024.

The Wu Tsai Human Performance Alliance invites proposals on athletic performance, injury prevention, and injury recovery to discover the biological principles that govern optimum performance, from the molecular level to the whole body.

Cancer disparities research fostering community engagement and cancer equity.